IVF with PGD (preimplantation genetic diagnosis) Egypt

Preimplantation genetic diagnosis (PGD) is a technique used to identify genetic defects in embryos created through in vitro fertilization (IVF) before transferring them into the uterus. Because only unaffected embryos are transferred to the uterus for implantation. 

PGD is performed in conjunction with IVF and is offered to fertile and infertile couples. PGD is recommended when embryos may be affected by a certain genetic condition. Only healthy and normal embryos are transferred into the mother's uterus, thus greatly reducing the risks of adverse outcomes such as miscarriages, pregnancy termination (after positive prenatal diagnosis) or birth defects (physical and/or mental). 

The preimplantation genetic diagnosis (PGD) procedure allows the screening of embryos for specific genetic traits before an embryo is implanted in a patient's uterus (that's the "preimplantation" part of "preimplantation genetic diagnosis". Also known as "embryo biopsy," PGD allows couples at risk for certain genetic disorders to determine which of their embryos are affected, and which are not, before the embryos are used to establish a pregnancy. 

We use PGD at CFC to detect abnormalities in chromosomes or hereditary conditions. The first reports of PGD used in conjunction with IVF treatments appeared in the early 1990s, and since then hundreds of normal, healthy babies have been born through the use of this advanced reproductive technology.